<?xml version="1.0" encoding="UTF-8"?>
<svg height="769.854" width="553.706894" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text x="70.276,75.661,78.484,81.484,82.984,87.524,89.71,92.511,94.179,95.679,99.055,101.822,103.652,106.661,108.329,109.829,114.368,116.554,119.355,121.023,122.523,126.551,128.449,130.447,131.947,136.043,139.16,141.949,144.751,146.507,148.007,149.507,152.597,155.416,158.291,161.291,162.791,168.248,171.122,173.12,174.62,177.449,179.234,182.331,185.331,186.831,188.766,191.611,193.563,195.147,197.843,200.638,203.329,206.251,208.073,211.124,214.139,215.639,217.139,218.639,220.139,221.639,223.139,224.639,226.139,227.639,229.139,230.639,232.139,233.639,235.139,236.639,238.139,239.639,241.139,242.639,244.139,245.639,247.139,248.639,250.139,251.639,253.139,254.639,256.139,257.639,259.139,260.639,262.139,263.639,265.139,266.639,268.139,269.639,271.139,272.639,274.139,275.639,277.139,278.639,280.139,281.639,283.139,284.639,286.139,287.639,289.139,290.639,292.139,293.639,295.139,296.639,298.139,299.639,301.139,302.639,304.139,305.639,307.139,308.639,310.139,311.639,313.139,314.639,316.139,318.367,323.148,326.173,327.952,330.821,333.891,335.753,338.087,339.587,341.48,344.48,345.98,349.105,351.872,353.753,355.468,358.297,361.366,363.228,365.562,367.062,371.594,373.313,375.183,378.183,379.683,382.787,384.972,387.774,389.442,390.942,395.762,398.632,401.849,403.665,405.693,408.519,410.97,412.873,415.64,417.521,419.23,422.336,425.515,427.849,429.349,432.334,434.332,435.832,438.604,441.7,443.53,446.571,448.458,453.398,458.14,461.392,464.492,467.156,468.656,471.76,473.758,475.258,479.999,483.116,485.921,489.157,491.395,494.191,497.287,499.189,502.059,505.16,507.983,511.07,514.257,516.591,518.091,521.292,523.083,525.539,528.356,531.204,533.659,536.484" y="44.424999999999955" svg_rhmargin="538.818" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:6.0px;font-style:NORMAL;font-weight:normal;">Med Oral Patol Oral Cir Bucal. 2019 Mar 1;24 (2):e217-30. Implants in patients with oral manifestations of autoimmune or muco-cutaneous diseases</text>
  <text x="296.941,300.493,304.493,308.493" y="759.854" svg_rhmargin="312.493" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:8.0px;font-style:NORMAL;font-weight:normal;">e218</text>
  <text x="70.866,75.277,81.25,85.096,89.951,95.504,101.483,107.492,112.47,116.402,119.451,124.876" y="212.17399999999998" svg_rhmargin="130.992" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-BoldMT;font-size:11.0px;font-style:NORMAL;font-weight:bold;">Introduction</text>
  <text x="70.866,76.373,81.654,85.38,90.553,93.249,98.224,102.73,105.51,108.17,112.798,117.789,122.789,125.449,129.412,134.442,138.954,143.45,148.0,151.954,155.844,158.504,161.988,166.428,169.329,173.878,177.768,180.428,185.22,188.55,191.21,194.202,202.005,206.87,209.668,214.296,219.241,221.888,225.282,230.329,233.697,238.742,242.663,245.625,250.606,255.683,260.708,265.718,270.663,273.644,276.342,280.782,283.442,286.835,291.473" y="224.17399999999998" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Survival and success rates of implant-prosthodontic re-</text>
  <text x="70.866,75.953,80.432,85.359,88.239,91.148,93.839,96.86,101.3,104.282,106.955,111.965,117.104,120.994,123.494,124.734,127.736,132.736,135.236,136.476,141.521,145.961,148.943,151.626,156.18,161.125,164.073,167.963,170.463,171.703,179.098,181.789,184.752,189.733,194.708,199.697,202.477,204.977,206.217,210.728,215.728,223.532,228.579,231.947,236.947,244.933,247.755,251.682,256.228,261.228,263.728,264.968,269.91,274.464,279.464,284.029,287.513,292.019,294.799" y="236.17399999999998" svg_rhmargin="297.299" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">habilitations in patients without compromised general </text>
  <text x="70.866,75.857,80.392,84.899,87.591,90.554,95.554,98.054,99.044,103.556,108.566,113.556,118.735,121.426,124.407,127.08,132.09,137.229,141.119,143.619,144.609,149.696,154.033,158.873,163.313,165.813,166.803,171.882,176.429,180.984,185.984,188.484,189.474,192.867,197.466,202.564,207.564,211.285,214.185,218.731,223.731,226.231,227.221,230.614,235.16,243.035,247.672,251.04,256.185,260.664,265.529,268.24,273.24,275.74,276.73,281.928,284.586,289.789,294.789" y="248.17399999999998" svg_rhmargin="297.289" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">health conditions have been reported remarkably high </text>
  <text x="70.866,75.306,80.146,84.7,89.7,92.2,92.83,95.832,100.832,103.332,103.962,111.948,114.651,119.71,123.04,125.54,126.17,130.798,135.789,140.789,143.289,143.919,146.612,151.622,156.598,161.468,164.827,167.727,172.291,176.018,183.798,186.298,186.923,191.881,196.926,200.853,205.417,209.143,214.118,218.558,221.539,224.212,229.222,234.361,238.325,240.825,243.325,243.955,248.446,252.08,254.98,259.545,262.875,265.375,266.005,269.18,274.015,276.915,279.608,284.448,291.485" y="260.174" svg_rhmargin="294.815" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">even in mid- and long-term observations, after follow-</text>
  <text x="70.866,75.904,80.904,83.404,88.503,93.067,96.692,99.365,104.442,109.615,113.505,116.005,120.799,124.129,126.629,131.667,136.667,139.167,142.057,147.057,149.557,154.05,159.05,161.55,166.55,169.88,172.38,176.795,181.61,186.107,190.654,195.2,200.378,203.379,208.354,213.354,215.854,220.347,225.347,227.847,232.707,237.243,241.88,245.369,249.259,251.759,254.574,258.908,262.039" y="272.174" svg_rhmargin="264.539" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">up periods of up to 10 or exceeding 10 years (1).</text>
  <text x="70.866,78.266,80.958,83.92,88.901,93.876,98.924,104.127,109.127,111.627,113.807,117.734,122.174,127.014,131.579,135.063,139.569,142.349,144.849,147.024,151.536,156.546,161.537,166.715,169.406,172.387,175.061,180.071,185.21,189.1,191.6,193.78,197.701,200.682,203.562,206.462,209.242,211.742,213.917,218.554,221.947,226.387,228.887,231.067,235.578,240.588,245.727,249.551,252.253,257.287,261.852,265.245,269.79,274.79,277.29,279.47,283.094,285.916,289.816,294.816" y="284.174" svg_rhmargin="297.316" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Although several conditions still are considered risk </text>
  <text x="70.866,74.206,78.776,83.273,86.163,91.163,94.652,98.542,101.042,101.602,104.777,109.777,113.107,115.607,116.167,121.201,125.755,130.7,133.72,138.227,141.007,143.507,144.067,147.058,154.862,159.726,162.525,167.152,172.097,174.877,177.377,177.937,182.984,186.352,191.26,196.549,201.541,206.586,210.409,213.231,217.121,219.621,220.181,223.182,228.182,230.682,231.242,239.022,243.568,248.745,251.443,255.925,260.432,263.331,266.042,271.042,273.542,274.102,278.614,283.614,291.473" y="296.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">factors for dental implant prognosis in medically com-</text>
  <text x="70.866,75.913,79.281,84.281,92.267,95.09,99.016,103.562,108.562,110.892,115.936,120.376,123.357,126.041,130.595,135.54,138.487,142.451,144.951,147.281,150.243,155.234,159.798,163.192,167.632,169.956,174.593,177.986,182.426,184.75,189.76,194.957,197.669,202.669,204.994,208.198,212.647,219.867,222.197,226.676,231.721,235.645,240.48,243.216,248.205,251.105,255.545,257.869,262.381,267.391,272.336,275.428,278.912,283.428,286.43,291.473" y="308.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">promised patients, there are only few absolute contrain-</text>
  <text x="70.866,76.044,78.741,83.224,87.664,90.646,93.319,98.329,103.468,107.358,109.858,110.788,113.963,118.963,122.293,124.793,125.723,128.686,133.884,136.706,140.596,143.096,144.026,147.119,150.512,155.047,159.487,162.57,170.35,174.905,179.85,182.63,185.13,186.054,191.079,196.07,199.051,201.725,206.735,211.788,214.288,216.788,217.718,224.069,229.013,234.167,238.131,240.631,243.131,244.056,249.235,252.057,255.983,260.519,265.107,269.034,273.474,275.974,276.898,281.41,286.42,291.473" y="320.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">dications for this treatment option. Thus, disease con-</text>
  <text x="70.866,73.958,77.326,82.161,84.941,86.981,91.773,95.103,97.143,101.654,106.664,111.655,116.833,119.525,122.506,125.179,130.189,135.328,139.218,141.258,144.259,149.274,153.839,157.232,161.767,166.356,170.179,173.181,178.156,183.156,185.196,188.158,193.149,197.589,199.629,203.253,206.075,209.975,215.159,217.659,219.699,224.326,229.317,234.317,236.357,239.359,244.35,249.528,252.224,257.397,260.099,265.151,270.344,274.851,277.76,280.728,285.244,289.789,294.789" y="332.174" svg_rhmargin="297.289" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">trol of conditions increasing the risk, and individualized </text>
  <text x="70.866,74.49,77.312,81.212,85.714,89.103,94.182,98.737,103.737,108.214,113.679,116.459,118.959,119.75,124.339,128.294,132.22,136.77,140.724,144.649,152.429,156.984,161.929,164.709,167.209,168.0,173.047,176.672,179.345,184.345,187.675,190.175,190.968,193.859,198.859,201.359,202.152,207.186,211.741,216.686,219.706,224.213,226.993,229.493,230.284,233.276,241.079,245.944,248.742,253.37,258.315,261.095,263.595,264.387,267.349,272.34,276.905,280.389,284.861,289.797,294.797" y="344.174" svg_rhmargin="297.297" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">risk-benefit assessment prior to dental implant therapy </text>
  <text x="70.866,78.741,83.094,88.094,90.754,95.833,100.273,102.933,107.445,112.455,117.594,121.417,124.12,129.154,133.718,137.111,141.657,146.657,149.317,157.087,162.093,165.485,169.925,172.585,175.577,183.38,188.478,193.478,197.199,200.22,204.847,209.792,212.572,215.232,218.194,223.281,227.909,232.909,235.569,238.531,243.522,247.962,250.622,255.8,258.623,262.547,267.547,270.896,275.93,280.495,283.825,286.485,291.485,294.815" y="356.174" svg_rhmargin="297.315" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">may be considered more important than the disorder or </text>
  <text x="70.866,74.49,77.312,81.212,86.507,91.507,94.237,98.748,103.758,108.749,113.927,116.619,119.6,122.273,127.283,132.283,135.013,137.704,140.652,144.578,148.912,151.796,155.126,157.856,160.887,165.423,168.554,171.054,173.784,180.898,185.738,192.8,197.24,202.08,206.645,209.685,212.185,214.915,219.949,224.503,229.448,232.468,236.975,239.755,242.485,245.476,253.28,258.145,260.943,265.57,270.515,273.295,276.025,278.988,283.979,288.543,291.473" y="368.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">risky condition itself (2). However, dental implant ther-</text>
  <text x="70.866,75.338,80.274,85.274,87.774,88.374,91.196,95.086,97.586,98.186,102.626,105.126,105.726,110.899,113.679,118.158,123.023,125.725,130.165,132.665,133.265,136.357,139.75,144.285,148.725,151.808,159.588,164.142,169.087,171.867,174.367,174.967,179.992,184.983,187.964,190.637,195.647,200.647,203.147,203.747,208.187,213.027,217.582,222.582,225.082,225.682,228.683,233.683,236.183,236.783,239.745,244.736,249.285,253.212,257.652,260.152,260.752,265.797,270.237,273.219,275.902,280.456,285.401,288.349,292.312,294.812" y="380.174" svg_rhmargin="297.312" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">apy is a viable treatment option even in these patients, </text>
  <text x="70.866,74.259,78.699,83.539,88.074,92.581,95.49,98.491,103.466,108.466,110.966,114.746,118.705,123.145,126.126,128.949,132.728,136.382,141.574,144.576,149.551,154.551,157.051,160.831,164.794,169.824,174.336,178.832,183.382,187.336,191.226,193.726,197.506,200.99,205.43,208.331,212.88,216.77,219.27,223.05,227.842,231.172,233.672,237.452,240.444,248.247,253.112,255.91,260.538,265.483,268.13,271.519,276.596,281.596,285.337,290.337,294.777" y="392.174" svg_rhmargin="297.277" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">revealing satisfying success rates of implant-borne </text>
  <text x="70.866,75.913,79.281,84.326,88.247,91.209,96.19,101.267,106.292,111.302,116.247,119.228,121.926,126.366,128.86599999999999,129.586,132.678,136.072,140.607,145.047,148.131,155.911,160.465,165.411,168.32,170.82,173.32,174.04,178.004,183.051,188.143,193.085,197.635,201.556,204.537,207.538,212.513,217.513,220.013,220.733,223.696,228.782,233.222,236.002,238.502,239.222,242.185,247.176,251.725,255.652,260.092,262.592,263.312,268.357,272.797,275.778,278.461,283.016,287.961,290.908,294.798" y="404.174" svg_rhmargin="297.298" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">prosthodontic treatment, suggesting that these patients </text>
  <text x="70.866,78.852,81.511,86.714,91.649,94.429,97.329,102.416,106.753,111.593,116.033,118.933,123.373,126.274,131.353,135.907,140.907,145.385,150.849,153.629,156.529,160.179,163.547,168.547,176.327,179.227,182.189,187.387,190.209,194.099,197.003,200.095,203.488,208.024,212.464,215.547,223.327,227.881,232.826,235.606,238.506,243.531,248.522,251.504,254.177,259.187,264.24,266.74,269.642,278.426,283.426,286.82" y="416.174" svg_rhmargin="291.26" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">might have a benefit from this treatment option. More</text>
  <text x="291.473" y="416.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-</text>
  <text x="70.866,75.697,80.537,85.102,88.142,90.642,92.916,95.879,100.87,105.419,109.346,113.786,116.059,119.452,124.002,127.965,133.115,135.808,138.755,142.645,144.925,149.48,154.495,159.006,163.981,169.261,172.745,177.228,182.17,186.61,188.883,191.773,196.773,199.048,203.879,208.719,213.284,216.671,221.182,226.182,233.962,238.402,240.675,243.584,246.576,254.562,257.253,260.274,264.714,267.695,270.369,275.379,280.518,284.408,286.688,291.48,294.81" y="428.174" svg_rhmargin="297.31" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">over, these results encourage to overcome limitations of </text>
  <text x="70.866,73.867,78.858,84.036,86.734,91.216,95.656,98.637,101.31,106.32,111.459,115.349,117.849,118.789,121.964,126.964,130.294,132.794,133.734,138.768,143.323,148.268,151.288,155.795,158.575,161.075,162.015,165.006,172.81,177.675,180.473,185.101,190.045,192.825,195.325,196.265,199.357,202.75,207.286,211.726,214.81,222.59,227.144,232.089,234.869,237.369,238.309,243.579,248.57,253.604,258.168,261.498,263.998,264.938,268.331,272.866,277.455,281.379,286.389,291.473" y="440.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">indications for dental implant treatment under reason-</text>
  <text x="70.866,75.345,80.21,82.912,87.352,89.852,91.452,96.079,101.07,106.07,108.57,110.17,114.653,119.29,122.684,127.021,130.699,135.849,138.629,141.129,142.729,146.649,149.55,154.148,159.079,166.474,169.296,173.223,177.663,180.163,181.763,184.855,188.248,192.784,197.224,200.307,208.087,212.641,217.586,220.366,222.866,224.466,227.859,232.25,237.424,240.416,248.196,252.75,257.75,260.25,261.85,266.438,270.328,272.828,274.428,277.391,282.382,286.946,290.339,294.779" y="452.174" svg_rhmargin="297.279" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">able and careful stepwise treatment regimen as there </text>
  <text x="70.866,75.503,78.897,83.337,85.837,87.037,90.039,94.984,97.884,102.448,105.798,110.976,113.798,117.74,122.18,124.92,129.785,132.695,135.696,140.792,145.429,149.171,154.171,156.671,157.871,162.343,167.425,172.472,175.84,180.863,185.432,189.827,194.954,197.454,199.954,201.154,204.832,209.982,212.881,215.661,218.161,219.361,222.323,227.314,231.879,235.363,239.835,244.771,249.771,252.271,253.471,258.065,263.354,268.345,272.91,276.303,280.857,285.872,290.369,294.809" y="464.174" svg_rhmargin="297.309" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">are interdisciplinary approach, full therapy adherence </text>
  <text x="70.866,75.793,80.793,83.203,86.165,91.156,95.596,98.006,103.051,107.491,110.472,113.155,117.71,122.655,125.602,129.492,131.902,136.491,140.381,142.791,149.853,154.186,157.086,159.866,162.276,166.864,170.754,173.164,177.085,180.177,183.801,186.499,190.996,193.776,196.186,200.698,205.707,210.699,215.876,218.568,221.549,224.222,229.232,234.372,238.262,240.672,245.464,248.794,251.204,254.186,256.844,262.047,266.982,269.762,272.172,275.565,280.127,284.609,289.116,292.015,294.795" y="476.174" svg_rhmargin="297.295" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">by the patients as well as strict conditions of tight recall </text>
  <text x="70.866,73.867,78.812,81.713,86.277,90.003,94.979,99.485,102.326,106.208,108.708" y="488.174" svg_rhmargin="111.208" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">intervals. </text>
  <text x="70.866,78.276,81.76,86.266,89.046,91.546,92.256,100.132,104.759,109.966,112.831,116.036,120.585,124.506,127.526,131.966,134.948,137.621,142.631,147.77,151.66,154.16,154.87,159.662,162.992,165.492,166.202,170.699,175.263,178.985,182.005,186.521,189.523,194.523,197.023,197.733,202.724,207.734,212.787,216.022,219.023,224.206,227.41,231.971,236.469,239.45,242.123,247.098,252.253,256.143,258.643,259.353,263.293,268.312,272.232,275.132,279.678,287.664,290.361,294.801" y="500.174" svg_rhmargin="297.301" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Oral manifestations of certain non-infectious systemic </text>
  <text x="70.866,76.044,78.866,82.793,87.328,91.917,95.843,100.393,104.283,106.783,108.013,113.013,115.513,116.743,121.361,129.131,134.141,139.116,144.116,146.616,147.846,150.808,155.799,160.344,168.124,170.624,171.854,176.308,181.297,184.187,189.081,192.072,200.161,207.893,213.163,218.163,222.603,225.103,227.603,228.833,231.333,232.563,237.713,240.402,244.898,249.462,252.947,257.387,260.368,263.065,267.905,272.345,274.845,277.345,278.575,283.551,288.701,291.473" y="512.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">diseases – among them autoimmune, ulcerative, bul-</text>
  <text x="70.866,73.559,78.534,83.688,87.652,90.152,93.075,98.075,101.405,104.327,109.787,114.834,118.202,123.177,128.331,132.221,135.145,140.145,143.068,147.705,151.098,155.538,158.459,162.109,165.502,170.047,175.1,180.115,184.669,189.614,192.456,195.167,200.167,203.09,207.572,212.664,217.949,221.433,225.771,230.746,235.186,238.087,242.632,247.632,250.555,255.482,260.482,263.404,267.331,271.892,276.404,281.414,286.405" y="524.174" svg_rhmargin="291.405" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">lous, or fibrous – are frequently aggravated by second</text>
  <text x="291.473" y="524.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-</text>
  <text x="70.866,75.503,79.245,84.245,86.745,88.115,92.452,95.98,99.184,103.746,108.243,111.191,115.081,117.581,118.951,123.743,127.073,129.57299999999998,130.943,133.905,138.896,143.336,145.836,147.206,152.476,157.467,162.501,167.066,170.327,173.038,178.23,181.231,186.206,191.206,193.706,195.076,200.121,204.561,207.524,212.504,217.55,221.373,224.195,228.085,230.585,231.955,234.957,239.957,242.457,243.827,248.872,253.312,256.293,258.976,263.531,268.476,271.423,275.313,277.813,279.183,283.146,288.281,291.473" y="536.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ary effects of the underlying pathosis in patients suf-</text>
  <text x="70.866,74.07,78.635,82.259,85.26,90.235,95.235,97.735,98.535,102.185,105.553,110.553,118.333,120.833,121.633,126.633,130.117,134.623,137.403,139.903,140.703,146.725,149.423,153.818,158.809,163.364,168.364,170.864,171.664,176.529,179.328,183.955,188.908,194.062,197.952,200.452,201.252,204.03,208.919,214.986,219.429,222.604,225.104,227.604,228.404,233.503,238.049,245.852,250.828,256.026,258.685,263.998,269.153,273.043,275.543,276.343,279.886,285.234,289.146,292.321,294.821" y="548.174" svg_rhmargin="297.321" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">fering from oral Lichen planus (oLp), pemphigus (Pe), </text>
  <text x="70.866,76.965,81.892,84.595,89.629,94.193,97.919,105.69,110.525,113.236,118.255,122.078,124.901,128.791,131.291,132.011,136.986,142.136,145.035,147.729,152.774,156.732,161.172,163.672,164.392,167.916,174.046,180.238,183.413,185.913,188.413,189.133,194.496,197.174,202.081,207.366,210.759,215.314,219.762,222.298,226.188,228.688,229.408,233.348,238.656,243.647,248.946,252.314,257.314,265.094,269.534,272.034,272.754,275.708,281.071,283.718,289.135,292.31,294.81" y="560.174" svg_rhmargin="297.31" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Epidermolysis bullosa (EB), Sjögren´s syndrome (SjS), </text>
  <text x="70.866,74.806,79.825,83.745,86.645,91.191,99.177,101.875,106.315,109.118,115.174,120.212,125.187,130.341,134.231,137.041,141.606,145.347,150.68,153.642,158.633,163.179,171.054,175.494,178.384,183.429,187.393,192.547,196.437,199.247,202.035,205.891,212.007,218.029,221.204,223.704,226.509,231.509,234.839,237.644,241.584,246.602,250.523,253.423,257.969,265.955,268.652,273.092,275.896,279.837,284.122,286.824,291.473" y="572.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">systemic Lupus erythematosus (sLE), or systemic scle-</text>
  <text x="70.866,74.234,79.279,83.103,85.925,89.816,92.316,95.104,99.004,104.574,108.467,111.598" y="584.174" svg_rhmargin="114.098" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">rosis (sSc).</text>
  <text x="70.866,77.117,82.008,86.458,90.284,94.624,97.124,97.711,102.656,106.996,109.878,112.461,116.915,121.76,124.607,128.397,130.897,131.484,135.348,140.383,143.811,146.915,151.379,154.609,157.109,157.696,161.245,164.513,169.413,177.093,179.593,180.18,183.081,188.3,193.77,198.288,206.276,214.051,218.391,221.181,226.081,229.722,234.055,236.455,238.955,239.542,244.592,247.18,251.577,256.041,259.309,264.184,269.238,273.102,275.502,278.002,278.59,283.054,286.322" y="596.174" svg_rhmargin="291.322" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">These patients suffer from inflammatory, ulcerous, ero</text>
  <text x="291.473" y="596.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-</text>
  <text x="70.866,74.59,77.186,81.926,86.266,88.766,89.646,92.248,96.698,100.421,102.994,107.904,112.943,116.807,119.207,121.707,122.587,126.311,128.908,133.32,137.702,142.042,144.542,145.422,149.262,154.455,162.159,167.05,169.84,174.74,182.558,186.422,188.822,191.322,192.202,196.044,200.426,204.964,208.194,210.694,211.574,214.649,219.549,223.175,230.951,235.291,238.172,240.746,245.656,250.69,253.09,255.59,256.47,261.37,264.6,267.1,267.98,270.789,273.68,281.566,284.158,287.078,291.473" y="608.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">sive lesions, sicca symptoms, scar formation, or limita-</text>
  <text x="70.866,73.747,76.32,81.23,86.13,88.19,92.882,96.112,98.167,105.837,110.712,115.601,118.464,123.364,125.419,130.344,135.343,139.797,144.904,147.806,152.68,157.483,159.883,161.943,167.403,171.865,176.276,181.186,186.077,191.189,195.726,199.367,204.267,206.327,210.564,213.992,217.096,221.558,225.955,228.802,232.592,234.647,239.339,242.569,244.624,247.487,252.378,256.827,260.654,264.994,267.049,272.127,274.85,278.676,283.112,287.6,291.473" y="620.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">tion of mouth opening. Secondary effects of these diseas-</text>
  <text x="70.866,75.315,79.105,81.88,86.417,89.71,94.05,96.825,101.236,106.136,113.839,118.786,122.054,126.954,134.84,137.563,141.389,145.835,150.735,153.509,157.945,162.285,165.167,168.068,172.943,177.843,180.618,185.145,190.036,194.936,197.711,201.545,208.642,213.048,215.848,218.441,223.181,230.475,233.377,238.252,243.143,245.543,248.318,253.024,257.489,260.757,265.702,269.522,272.313,277.208,285.095,287.775,292.306,294.805" y="632.174" svg_rhmargin="297.305" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">es are compromised eating and swallowing, xerostomia, </text>
  <text x="70.866,75.32,80.538,85.525,90.053,94.968,99.364,103.809,108.709,111.469,114.993,117.715,121.514,126.414,129.174,133.866,137.096,139.856,144.239,148.776,152.3,154.884,159.333,163.123,165.883,170.41,175.301,180.201,182.961,187.96,192.424,195.948,198.522,203.499,208.424,213.334,218.179,221.06,223.651,226.532,229.255,233.045,235.805,240.739,245.201,249.583,253.835,258.168,260.568,263.328,267.735,270.331,275.071,279.517,284.251,286.95,291.487,294.817" y="644.174" svg_rhmargin="297.317" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">enhanced risk of caries and periodontitis decay, alveolar </text>
  <text x="70.866,74.39,76.992,81.959,86.801,91.141,93.641,95.541,99.881,102.873,106.141,111.066,115.942,120.75,125.083,127.483,129.983,131.883,135.725,140.107,144.645,147.875,150.375,152.275,155.157,157.879,161.733,165.597,170.512,174.852,177.352,179.252,182.327,187.227,190.853,198.628,202.968,205.849,208.422,213.332,218.367,220.767,223.267,225.167,229.621,234.839,239.826,244.353,249.268,253.665,258.11,263.01,265.51,267.41,270.934,273.656,277.456,282.356,284.856,286.756,291.448,294.778" y="656.174" svg_rhmargin="297.278" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ridge atrophy, scar tissue formation, enhanced risk of </text>
  <text x="70.866,75.766,79.15,83.556,86.236,88.815,92.664,97.617,102.71,107.227,114.898,119.773,124.827,128.617,131.196,135.593,139.826,142.625,145.305,147.884,152.266,156.803,160.09,164.43,167.331,172.222,177.122,184.897,189.428,191.828,194.407,198.934,203.825,208.725,211.304,215.715,220.615,228.319,233.265,236.789,239.512,243.338,247.678,250.257,253.98,256.582,261.517,265.857,268.436,272.673,276.101,279.205,283.667,288.064,290.911,294.803" y="668.174" svg_rhmargin="297.303" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">oral squamous cell carcinoma, and comprise side effects </text>
  <text x="70.866,75.558,78.788,81.288,83.548,87.388,92.307,96.128,98.928,103.373,111.26,113.857,118.196,120.696,122.956,127.483,132.328,135.21,137.846,140.98,143.881,149.1,154.57,159.088,167.076,174.851,179.196,181.986,186.891,190.532,195.432,197.932,200.192,205.097,208.327,210.827,213.088,215.979,223.967,231.6,236.77,241.671,246.217,249.457,257.128,262.105,267.057,272.107,274.805,279.15,282.031,284.932,289.807,294.807" y="680.174" svg_rhmargin="297.307" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">of systemic anti-inflammatory or immune-modulating </text>
  <text x="70.866,78.546,82.992,88.07,90.667,95.049,99.389,102.27,104.843,109.753,114.706,117.106,119.606,120.736,126.987,131.831,136.885,140.749,143.149,145.649,146.779,151.186,153.985,156.665,159.165,160.295,163.157,168.048,172.498,176.324,180.664,183.164,184.294,189.239,193.579,196.46,199.044,203.498,208.343,211.19,214.98,217.48,218.61,223.597,227.835,232.575,236.915,239.415,240.545,243.446,248.346,250.846,251.976,256.387,261.287,269.276,276.946,281.856,286.756,289.256,290.386,294.824" y="692.174" svg_rhmargin="297.324" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">medication. Thus, all these patients have in common a </text>
  <text x="70.866,74.59,77.148,82.338,87.445,90.347,95.731,100.114,104.641,109.486,112.166,114.666,116.5,119.793,124.239,129.191,134.121,138.518,141.4,143.973,148.883,153.783,156.283,158.118,162.809,166.039,168.539,170.375,175.327,180.42,184.827,187.636,190.227,193.225,198.125,200.625,202.459,207.151,210.381,212.881,214.716,217.526,220.291,223.395,227.654,230.054,232.554,234.389,243.074,247.974,251.267,255.712,260.443,265.183,269.648,272.587,274.987,277.487,279.322,284.222,287.606,292.013,294.791" y="704.174" svg_rhmargin="297.291" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">significant reduction of quality of life. Moreover, oral </text>
  <text x="70.866,75.674,80.409,85.483,88.066,92.52,97.42,101.76,104.16,106.66,108.74,113.674,118.128,122.973,125.894,130.3,132.98,135.48,137.56,140.552,143.845,148.28,152.62,155.603,163.283,167.738,172.582,175.262,177.762,179.842,182.743,187.588,190.389,194.853,198.479,203.219,207.673,212.518,215.4,217.973,222.883,227.922,231.712,234.212,236.292,240.819,245.71,250.61,253.11,255.19,259.639,263.507,268.506,272.967,277.307,279.987,284.393,287.193,289.804,294.804" y="716.174" svg_rhmargin="297.304" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">hygiene, dental treatment interventions and especially </text>
  <text x="70.866,77.828,82.263,86.8,90.324,93.226,98.101,103.001,105.501,107.641,115.273,120.203,124.614,129.559,133.418,137.824,140.48,143.769,148.746,153.646,157.287,162.187,166.527,169.027,171.167,176.101,180.555,185.4,188.422,193.602,196.895,201.344,205.134,207.634,209.774,214.311,217.604,221.944,224.444,226.584,229.475,237.178,242.177,246.623,251.557,256.002,260.994,263.394,265.894,268.034,274.286,279.176,283.641,286.934,291.473" y="728.174" svg_rhmargin="294.803" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">wearing mucosal-borne dentures are impeded. There-</text>
  <text x="70.866,73.941,78.841,82.134,86.474,88.874,91.374,92.391,95.253,100.144,104.484,106.984,108.001,112.954,117.869,122.318,126.139,129.02,131.593,136.503,141.403,143.903,144.92,149.457,152.981,155.704,159.53,163.98,167.843,170.243,172.743,173.76,176.525,179.755,182.255,183.272,186.134,191.025,195.474,199.301,203.641,206.141,207.158,212.103,216.443,219.324,221.907,226.362,231.207,234.054,237.844,240.344,241.36,249.246,251.805,256.908,261.743,264.423,266.923,267.939,272.918,277.373,282.273,286.65,292.015,294.793" y="740.174" svg_rhmargin="297.293" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">fore, the question arises, if these patients might benefit </text>
  <text x="70.866,77.604,82.614,87.629,91.913,94.649,99.803,103.626,106.3,111.31,116.449,120.127,122.907,125.692,133.049,138.208,140.91,145.944,150.278,153.187,156.189,161.189,165.739,169.629,172.419,175.812,180.203,185.242,189.88,193.229,198.407,201.408,206.383,211.383,214.173,217.164,224.967,229.832,232.631,237.258,242.203,244.983,247.768,250.861,254.254,258.789,263.229,266.312,274.092,278.647,283.592,286.372,289.157,293.949,297.279,300.069,305.114,309.554,312.536,315.219,319.773,324.719,327.666,331.556,334.346,341.741,344.432,347.395,352.395,355.185,360.074,366.141,371.017,373.517,376.307,381.655,386.095,388.595,391.385,397.514,404.172,406.672,409.462,414.824,417.472,423.069,425.569,428.359,432.216,438.326,444.436,447.221,452.221,455.551,458.341,462.243,467.814,472.254,475.044,480.069,485.069,487.859,492.85,497.812,500.592,503.377,507.792,512.961,515.783,519.704,522.484,525.269,530.26,535.26,538.59" y="84.09900000000005" svg_rhmargin="541.09" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Conclusions: Guidelines regarding implant treatment of patients with oLp, Pe, EB, SjS, sLE or sSc do not exist nor </text>
  <text x="70.866,75.503,78.897,83.337,85.464,89.976,94.986,99.931,103.023,106.507,111.024,114.025,119.016,124.194,126.891,131.374,135.814,138.795,141.796,146.771,151.771,153.901,158.412,163.422,168.413,173.591,176.282,179.264,181.937,186.947,192.086,195.976,198.107,203.141,207.619,213.407,218.407,222.953,228.045,230.545,232.674,236.231,244.034,248.899,251.698,256.325,261.27,264.05,266.178,270.142,275.422,279.148,284.321,287.017,291.992,296.498,299.278,301.406,304.89,309.33,312.23,316.78,320.67,322.801,327.593,330.923,333.052,338.097,342.537,345.518,348.201,352.756,357.701,360.648,364.538,366.669,371.161,374.689,377.893,382.454,386.952,389.852,394.398,399.398,401.527,406.165,409.558,413.998,416.126,420.637,425.637,433.44,438.485,443.123,446.607,451.085,455.951,458.653,463.093,465.221,468.111,473.111,475.24,478.203,483.184,488.229,492.156,496.596,498.723,503.515,506.845,508.975,513.966,518.501,523.008,525.7,528.663,533.57,538.57" y="96.09900000000005" svg_rhmargin="541.07" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">are contraindicating conditions defined. Implant survival rates of patients affected are comparable to those of healthy </text>
  <text x="70.866,75.911,80.351,83.333,86.016,90.571,95.516,98.463,102.345,104.845,107.695,112.904,117.904,121.234,124.084,127.076,134.879,139.744,142.542,147.17,152.115,154.762,158.156,163.203,166.571,171.616,175.537,178.499,183.49,187.968,190.949,193.646,198.086,200.936,204.329,208.769,213.856,218.334,223.262,226.142,229.051,231.742,234.763,239.203,242.185,244.858,249.868,254.868,257.718,262.511,265.841,268.691,273.736,278.176,281.157,283.84,288.395,293.34,296.287,300.177,303.027,310.422,313.113,316.076,321.076,323.926,329.275,333.715,336.565,341.192,346.183,351.183,354.033,357.89,364.0,370.11,372.96,377.951,382.951,385.801,390.312,395.322,400.337,404.621,407.357,412.511,416.334,419.008,424.018,429.157,433.047,435.897,440.38,445.007,450.007,452.857,457.936,462.376,465.226,470.525,474.009,478.356,485.867,490.867,493.717,498.769,503.784,508.224,511.074,513.964,518.964,521.814,524.612,529.181,533.567,538.567" y="108.09900000000005" svg_rhmargin="541.067" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">patients. For implant-prosthetic rehabilitation of patients with Pe and sLE no conclusions can be drawn due to lack </text>
  <text x="70.866,75.658,78.988,81.955,85.919,91.054,94.703,100.187,104.627,107.31,111.865,116.81,119.59,122.555,126.839,129.749,132.75,137.957,140.654,145.137,149.643,152.423,155.389,160.601,165.041,168.061,172.61,175.11,178.077,181.634,189.437,194.302,197.101,201.728,206.673,209.32,212.715,217.761,221.13,226.175,230.095,233.058,238.049,242.526,245.507,248.205,252.645,255.61,258.703,262.096,266.631,271.071,274.154,281.934,286.489,291.434,294.214,297.179,302.493,307.652,310.354,315.388,319.722,322.631,325.632,330.632,335.182,339.072,342.04,345.434,349.825,354.864,359.502,362.851,368.029,371.03,376.005,381.005,383.972,388.963,393.498,398.005,400.697,403.66,408.568,413.568,416.535,421.58,426.02,429.001,431.685,436.239,441.184,444.132,448.022,450.99,454.867,459.848,464.823,469.973,472.666,477.666,480.633,485.712,490.152,493.118,497.038,500.131,503.755,506.452,510.949,513.791,516.502,521.502,524.469,527.644,532.479" y="120.09900000000005" svg_rhmargin="535.259" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">of sufficient clinical data. Implant-prosthetic treatment guidelines regarding healthy patients should be strictly fol</text>
  <text x="535.253" y="120.09900000000005" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-</text>
  <text x="70.866,73.559,78.399,85.461,90.007,95.201,97.701,100.201,105.176,110.165,112.945,115.445,119.093,122.486,127.031,132.084,137.099,141.654,146.599,149.379,151.879,155.27,159.832,164.314,168.821,171.72,174.5,177.0,179.821,183.711,186.211,189.605,194.167,198.678,203.678,211.767,219.547,224.101,229.092,234.126,238.672,243.672,246.172,249.173,254.173,256.673,261.718,266.158,269.139,271.822,276.377,281.322,284.269,288.159,290.659,295.152,298.68,301.884,306.446,310.943,313.844,318.389,323.389,325.889,333.284,335.975,338.937,343.937,346.437,351.326,357.393,362.269,364.769,367.269,372.631,375.279,380.876,383.376,385.876,392.006,398.664,401.164,403.664,409.174,414.746,419.145,421.645,424.145,429.494,433.934,436.434,441.434,444.764,447.264,451.121,457.231,463.44" y="132.09900000000005" svg_rhmargin="465.94" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">lowed, but frequent recall is recommended in patients affected with oLp, SjS, EB, SSc, Pe or sLE.</text>
  <text y="144.09900000000005" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="73.366" x=""/>
  <text x="70.866,77.306,81.838,86.177,88.677,90.067,96.66,101.638,105.484,110.549,114.26" y="156.09900000000005" svg_rhmargin="117.59" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-BoldItalicMT;font-size:10.0px;font-style:ITALIC;font-weight:bold;">Key words:</text>
  <text style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="119.99" y="156.09900000000005" x=""/>
  <text x="121.376,128.597,133.063,138.016,140.746,145.657,148.337,150.837,152.227,154.954,162.128,167.028,169.724,174.727,179.68,182.488,186.285,188.685,191.185,192.575,195.302,202.476,207.376,210.072,215.075,220.028,222.708,225.208,226.598,230.491,235.511,240.496,245.493,250.429,254.383,257.071,261.537,266.437,268.937,270.327,275.282,279.096,284.086,287.893,290.59,295.563,300.075,303.85,306.658,310.454,312.854,315.354,316.744,321.68,325.486,330.397,333.077,335.577,336.967,339.588,342.3,346.708,351.681,356.147,361.047,363.547,364.937,369.837,372.534,377.536,382.571,387.648,391.445,393.845,396.345,397.735,402.756,405.348,410.248,415.393,419.197,423.663,427.622,430.514,434.304,436.804,438.194,442.158,446.612,451.622,456.602,460.415,465.395,472.553,477.031,479.431,481.931,483.321,487.812,492.746,495.496,500.461,504.923,508.954,516.148,521.025,523.736,528.149,531.923,534.731,538.623" y="156.09900000000005" svg_rhmargin="541.123" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-ItalicMT;font-size:10.0px;font-style:ITALIC;font-weight:normal;">Dental implants, implant supported prosthesis, oral lichen planus, Sjögren´s syndrome, epidermolysis </text>
  <text x="70.866,75.902,80.846,83.45,86.109,91.099,94.905,99.988,102.388,104.788,108.752,113.165,116.972,119.662,124.138,131.268,133.98,138.319,140.719,144.535,148.885,151.539,156.001,159.814,164.804,168.579,171.387,175.187,177.587,179.987,184.946,189.423,196.596,201.521,206.465,209.062,214.226,219.303,223.103,225.504,227.904,231.867,236.28,240.087,242.777,247.253,254.383,257.095,261.434,263.834,266.554,271.574,276.624,281.701,285.493,287.893,292.355,296.54,300.941,303.637,308.61,313.087,320.283,325.261,327.987,332.977,336.87,341.947,345.728" y="168.09900000000005" svg_rhmargin="348.228" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-ItalicMT;font-size:10.0px;font-style:ITALIC;font-weight:normal;">bullosa, systemic sclerosis, pemphigus, systemic lupus erythematosus.</text>
  <text x="314.646,318.195,321.463,326.363,334.043,336.543,337.593,340.484,348.187,352.952,355.651,360.178,365.023,367.57,370.859,375.836,380.736,384.377,389.277,393.617,396.117,397.162,402.109,405.377,410.322,414.142,417.005,421.896,426.345,430.172,434.621,438.485,440.885,443.385,444.435,447.225,452.125,454.625,455.675,459.912,464.623,469.417,472.019,476.919,479.419,480.469,484.784,489.756,492.556,497.011,502.05,505.773,508.369,513.109,517.449,519.949,520.994,525.406,530.316,535.253" y="211.65800000000002" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">from implant-borne prostheses, to avoid extensive con-</text>
  <text x="314.646,317.566,322.036,326.433,329.113,331.513,336.492,340.87,343.862,350.824,355.271,359.725,364.625,367.025,371.972,375.24,380.185,384.006,386.868,391.759,396.208,400.035,404.484,408.274,410.674,415.201,420.092,424.992,427.392,430.254,435.145,439.485,441.885,446.785,450.169,454.575,457.255,459.655,467.288,472.218,476.629,481.574,485.432,489.881,492.381,494.681,497.081,499.481" y="223.65800000000002" svg_rhmargin="501.981" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">tact between prostheses and the oral mucosa. </text>
  <text x="314.646,320.997,325.988,330.428,333.353,337.869,340.861,348.641,351.571,356.363,359.693,362.623,365.586,370.784,373.606,377.496,380.426,384.366,389.385,393.305,396.205,400.751,408.626,413.066,416.047,418.744,423.184,426.109,429.502,433.942,439.114,441.798,446.246,453.466,456.396,461.188,464.518,467.448,470.411,475.402,479.842,482.766,485.676,488.367,491.267,495.832,499.316,503.756,506.878,512.158,515.551,519.991,522.915,530.112,534.7,538.59" y="235.65800000000002" svg_rhmargin="541.09" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">The aim of this systematic review of the literature was </text>
  <text x="314.646,317.536,322.536,324.816,328.209,332.649,337.489,342.025,346.531,349.368,351.868,354.148,357.013,360.343,362.623,365.614,373.417,378.282,381.081,385.708,390.653,393.433,395.713,400.76,404.128,409.173,413.094,416.056,421.047,425.524,428.506,431.203,435.643,437.923,441.015,444.408,448.944,453.384,456.468,464.248,468.802,473.747,476.527,478.807,483.599,486.929,489.209,494.254,498.694,501.675,504.359,508.913,513.858,516.806,520.696,522.976,526.939,532.074,535.253" y="247.65800000000002" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">to reveal, if implant prosthetic treatment of patients suf-</text>
  <text x="314.646,317.85,322.415,326.039,329.04,334.015,339.015,341.399,345.049,348.417,353.417,361.197,363.58,368.469,374.535,379.411,381.911,384.296,389.644,394.084,396.584,398.968,405.098,411.756,414.256,416.64,422.003,424.65,430.248,432.748,435.132,438.989,445.099,451.209,453.592,458.592,461.922,464.307,468.208,473.78,478.22,480.603,485.086,489.713,494.713,497.098,502.177,506.617,509.0,513.511,518.521,523.66,527.484,530.186,535.253" y="259.658" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">fering from oLp, Pe, EB, SjS, sLE or sSc can be consid-</text>
  <text x="314.646,319.211,322.604,327.149,332.149,334.649,339.089,341.589,346.635,350.003,355.003,362.989,365.811,369.635,372.636,377.611,382.611,385.111,388.204,391.597,396.132,400.572,403.655,411.435,415.99,420.935,423.715,426.215,431.238,436.229,439.21,441.884,446.894,451.947,454.447" y="271.658" svg_rhmargin="456.947" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ered a promising treatment option. </text>
  <text x="314.646,325.03,330.43,334.141,338.974,344.089,347.187,352.777,355.835,358.585,364.097,370.122,376.238,378.988,389.246,394.13,397.785,403.796,409.349,415.503" y="296.858" svg_rhmargin="419.782" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-BoldMT;font-size:11.0px;font-style:NORMAL;font-weight:bold;">Material and Methods</text>
  <text x="314.646,320.997,325.988,330.428,332.808,335.983,341.076,345.572,350.726,354.653,359.198,364.198,366.579,371.632,376.647,381.197,385.117,388.099,390.772,395.782,400.782,403.163,410.359,414.948,418.626,421.406,423.786,430.972,436.17,438.868,443.263,448.263,450.644,453.635,461.438,466.303,469.102,473.729,478.674,481.454,483.833,487.797,493.077,496.803,501.976,504.672,509.647,514.154,516.934,519.313,522.797,527.237,530.137,534.686,538.576" y="308.858" svg_rhmargin="541.076" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">The focused question was: which implant survival rates </text>
  <text x="314.646,321.708,326.272,329.665,334.105,336.605,337.685,341.078,345.677,350.775,355.775,359.496,362.396,366.941,371.941,374.441,375.521,378.523,383.523,386.023,387.103,392.148,396.588,399.569,402.252,406.807,411.752,414.699,418.589,421.089,422.169,426.133,431.268,434.796,438.0,442.564,446.188,449.19,454.165,459.165,461.665,462.745,466.394,469.762,474.762,482.542,485.042,486.117,493.85,498.88,503.391,508.484,512.981,517.97,520.99,525.617,530.617,535.253" y="320.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">were reported in patients suffering from mucocutane-</text>
  <text x="314.646,319.621,324.775,328.665,330.827,335.827,339.157,341.318,345.772,350.761,353.651,358.545,361.546,366.866,372.436,377.054,385.142,393.017,397.457,400.347,405.347,409.088,414.088,416.249,421.427,424.249,428.176,432.711,437.3,441.226,445.776,449.666,451.828,456.717,462.784,467.66,470.16,472.321,477.669,482.109,484.609,486.77,492.9,499.558,502.058,504.218,509.581,512.228,517.826,520.326,522.487,526.343,532.459,538.569" y="332.858" svg_rhmargin="541.069" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ous or autoinflammatory diseases oLp, Pe, EB, SjS, sLE </text>
  <text x="314.646,319.651,322.981,325.481,329.381,334.951,338.945,343.384" y="344.858" svg_rhmargin="345.884" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">or sSc? </text>
  <text x="314.646,321.866,324.366,326.536,330.476,335.495,339.416,342.316,346.861,354.737,359.177,362.159,364.856,369.296,371.796,373.966,376.875,379.567,382.467,387.032,390.516,394.956,398.077,403.357,406.75,411.19,413.69,415.86,419.786,424.322,428.959,432.346,436.742,441.742,444.242,446.412,453.608,458.197,462.087,464.587,466.757,471.856,476.42,480.002,483.177,488.177,491.903,499.683,504.229,509.424,511.924,514.424,516.594,521.748,525.572,528.573,533.548,538.548" y="356.858" svg_rhmargin="541.048" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">A systematic literature search was performed, using </text>
  <text x="314.646,318.98,321.682,326.243,330.741,333.833,337.201,342.211,347.418,350.115,354.555,357.055,357.785,360.694,363.386,366.286,370.85,374.334,378.774,381.895,387.175,390.568,395.008,397.508,398.238,403.45,407.89,410.911,415.389,420.411,424.999,428.926,433.475,437.365,439.865,440.595,444.138,449.941,454.985,459.893,468.69,473.236,478.589,481.697,490.495,495.04,500.209,503.119,506.12,511.12,515.56,518.06,520.56,521.29,527.41,535.253" y="368.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">electronic literature databases (PubMed/Medline, Em-</text>
  <text x="314.646,319.668,324.256,328.183,332.094,335.424,337.924,339.864,344.492,349.483,354.483,356.983,358.923,368.051,374.154,379.594,386.814,389.314,391.254,395.881,400.872,405.872,408.372,410.312,414.239,418.774,423.412,426.798,431.194,436.194,438.694,440.634,443.534,448.099,451.825,459.605,462.105,464.04,468.551,473.551,481.299,486.226,489.227,494.323,498.763,501.745,504.418,509.428,514.567,518.457,520.957,522.897,525.686,529.612,534.16,538.6" y="380.858" svg_rhmargin="541.1" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">base) and MESH and search term combinations (see </text>
  <text x="314.646,320.093,324.572,329.437,332.139,336.579,339.079,340.669,345.003,348.134,350.634,353.134,354.724,361.075,366.067,370.507,373.007,374.597,378.537,383.556,387.476,390.377,394.922,402.797,407.237,410.218,412.915,417.355,419.855,421.445,424.838,429.278,434.451,437.134,441.582,448.802,451.302,452.892,457.684,461.014,463.514,465.104,468.066,473.057,477.497,479.997,481.587,484.496,487.187,490.087,494.652,498.136,502.576,505.697,510.977,514.37,518.81,521.31,522.9,530.096,534.685,538.575" y="392.858" svg_rhmargin="541.075" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Table 1). The systematic review of the literature was </text>
  <text x="314.646,319.671,324.681,329.681,334.121,336.621,337.991,341.384,345.717,348.516,352.956,355.857,360.402,365.402,367.902,369.272,372.163,377.163,379.663,381.033,383.996,388.987,393.427,395.927,397.292,402.627,405.823,412.478,419.698,422.198,423.568,426.743,431.743,435.469,443.344,447.784,450.611,453.111,455.611,456.981,462.783,467.827,472.692,475.602,478.299,482.781,487.221,490.202,492.875,497.885,503.024,506.914,509.414,510.784,514.178,518.776,523.874,528.874,532.595,535.253" y="404.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">done related to the PICO format. Publications report-</text>
  <text x="314.646,317.647,322.622,327.622,330.242,335.252,340.252,342.872,347.917,352.357,355.338,358.021,362.576,367.521,370.468,374.358,376.984,380.947,386.082,389.611,392.815,397.379,401.003,404.004,408.98,413.98,416.6,420.249,423.617,428.617,436.397,439.017,443.906,449.972,454.848,457.348,459.968,465.316,469.756,472.256,474.876,481.005,487.663,490.163,492.783,498.145,500.793,506.39,508.89,511.51,515.367,521.477,527.587,530.207,535.207,538.537" y="416.858" svg_rhmargin="541.037" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ing on patients suffering from oLp, Pe, EB, SjS, sLE or </text>
  <text x="314.646,318.548,324.119,328.559,331.059,331.623,335.282,340.38,345.405,350.38,355.53,358.328,362.768,365.749,368.422,373.432,378.016,381.191,383.691,386.191,386.761,392.031,397.022,402.056,406.62,409.968,414.885,419.779,422.78,427.755,432.755,435.255,435.825,440.109,443.018,446.02,451.227,453.924,458.407,462.913,465.693,468.193,468.757,473.91,477.837,482.277,484.777,485.341,490.133,493.463,495.963,496.528,501.562,506.116,511.062,514.082,518.588,521.368,523.868,524.432,527.423,535.253" y="428.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">sSc (population), undergoing clinical use of dental im-</text>
  <text x="314.646,319.511,322.309,326.937,331.882,334.529,337.923,342.97,346.338,351.383,355.304,358.266,363.257,367.735,370.716,373.413,377.853,380.143,383.536,387.976,393.063,397.542,402.469,405.349,408.258,410.949,413.97,418.41,421.392,424.065,429.075,434.075,436.365,439.535,442.536,447.481,450.381,454.946,458.672,463.512,468.066,473.011,475.993,478.666,483.676,488.26,491.59,493.88,498.507,503.498,508.498,510.788,514.181,518.621,523.461,527.997,532.503,535.253" y="440.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">plant-prosthetic rehabilitation (intervention) and reveal-</text>
  <text x="314.646,317.647,322.622,327.622,330.122,331.212,335.132,338.254,343.297,348.325,353.325,355.825,356.915,361.949,366.498,370.322,372.98,378.27,383.405,385.905,388.405,389.495,393.977,398.919,403.359,405.859,408.359,409.449,414.391,418.946,423.937,428.971,433.535,436.575,439.075,441.575,442.665,447.619,452.878,460.626,465.705,470.269,473.599,476.099,477.189,481.981,485.311,487.811,488.901,493.946,498.386,501.367,504.05,508.605,513.55,516.497,520.387,522.887,523.977,528.605,533.596,538.596" y="452.858" svg_rhmargin="541.096" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ing study design, age, gender, number of patients and </text>
  <text x="314.646,317.637,325.441,330.306,333.104,337.731,342.676,345.624,349.587,352.087,354.587,355.617,358.792,363.627,366.526,369.219,374.059,381.096,384.471,389.509,394.509,397.009,398.039,403.138,407.702,411.326,414.0,419.077,424.077,426.577,427.607,432.399,435.729,438.229,439.259,444.259,447.589,450.089,451.118,455.535,460.349,464.846,469.393,473.939,479.117,482.118,487.093,492.093,494.593,495.623,500.363,505.363,507.863,508.893,516.663,521.673,526.618,529.581,534.711,538.601" y="464.858" svg_rhmargin="541.101" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">implants, follow-up period of or exceeding 12 months </text>
  <text x="314.646,319.273,324.264,329.264,332.254,335.246,343.049,347.914,350.712,355.34,360.285,363.065,366.055,370.019,375.299,379.025,384.198,386.894,391.869,396.376,399.156,402.146,405.63,410.07,412.971,417.411,420.401,423.179,428.154,433.143,436.053,440.564,445.564,453.344,457.256,460.431,462.931,465.921,470.548,475.539,480.539,483.529,488.504,493.548,498.413,501.322,504.145,508.021,513.012,517.558,522.558,525.548,530.627,535.253" y="476.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">and implant survival rate (outcome), and published be-</text>
  <text x="314.646,317.738,324.8,329.348,333.902,338.902,341.402,342.032,346.622,351.505,356.512,361.512,364.012,364.637,369.265,374.256,379.256,381.756,382.381,389.676,394.238,398.734,403.279,411.027,416.106,420.67,424.0,426.5,427.13,432.106,436.595,440.856,445.856,448.356,448.986,451.987,456.987,459.487,460.117,466.245,471.22,476.302,479.211,482.034,485.91,490.91,493.41,494.04,499.04,502.37,504.87,505.5,512.808,517.373,521.099,528.974,533.602,538.602" y="488.858" svg_rhmargin="541.102" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">tween 1980 and December 2017 in English or German </text>
  <text x="314.646,317.444,322.072,327.047,332.361,337.554,342.036,346.978,351.418,353.588,360.65,365.215,368.608,373.048,375.218,378.219,383.234,387.519,390.254,395.297,400.331,404.877,409.969,412.469,414.639,421.859,424.029,428.541,433.551,438.496,441.588,444.956,449.791,452.571,454.741,460.026,463.394,468.369,473.407,478.407,480.577,487.774,492.362,496.252,498.422,501.22,505.789,510.175,515.431,518.432,523.407,528.407,530.577,533.578,538.578" y="500.858" svg_rhmargin="541.078" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">language were included. A control group was lacking in </text>
  <text x="314.646,322.416,327.461,331.382,334.162,336.462,341.254,344.584,346.884,351.859,356.903,361.768,364.677,367.375,371.857,376.297,379.278,381.951,386.961,392.1,395.982,398.482,400.782,406.584,411.628,416.493,419.402,422.1,426.582,431.022,434.003,436.676,441.686,446.825,450.715,453.015,460.076,464.641,468.034,472.474,474.774,479.19,484.005,488.289,491.025,496.068,501.102,505.647,510.842,513.342,515.642,518.507,521.837,524.137,527.312,532.312,535.253" y="512.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">most of publications. Publications were excluded, if for-</text>
  <text x="314.646,322.521,326.961,329.942,332.615,337.625,342.625,344.705,349.497,352.827,354.907,362.782,367.289,370.198,372.856,378.146,383.242,387.87,392.815,395.595,397.669,400.791,406.051,413.821,418.796,424.076,427.406,429.486,432.487,437.487,439.567,442.529,447.52,451.96,454.035,459.026,463.561,468.156,473.156,475.236,479.863,484.854,489.854,491.934,496.934,501.495,505.881,510.881,512.961,516.354,520.745,525.919,528.594,533.604,538.604" y="524.858" svg_rhmargin="541.104" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">mation of malignant tumour in the head and neck region </text>
  <text x="314.646,317.647,322.592,325.493,330.057,333.638,336.842,341.407,344.8,349.345,354.345,356.845,364.24,366.931,369.894,374.894,377.394,380.385,388.188,393.053,395.852,400.479,405.424,408.204,410.704,415.704,419.034,421.534,426.58,431.02,434.001,436.685,441.239,446.184,448.964,451.464,455.426,460.706,464.432,469.605,472.301,477.276,481.783,484.538,487.038" y="536.858" svg_rhmargin="489.538" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">interfered with implant or patient survival. </text>
  <text x="314.646,320.448,325.492,330.358,333.267,335.964,340.447,344.887,347.868,350.542,355.552,360.691,364.581,367.081,368.128,375.19,379.754,383.147,387.587,390.087,391.132,393.834,398.868,403.422,408.367,411.349,414.351,419.822,424.367,429.367,431.867,432.913,437.54,442.531,447.531,450.031,451.077,455.555,460.601,464.521,467.613,471.097,475.667,480.164,483.112,487.002,489.502,490.549,497.611,502.175,505.568,510.008,512.508,513.553,517.993,522.968,527.475,530.21" y="548.858" svg_rhmargin="535.21" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Publications were identified and abstracts were evalu</text>
  <text x="535.253" y="548.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-</text>
  <text x="314.646,319.086,321.986,326.531,331.531,333.761,336.762,341.753,346.787,351.386,356.485,361.039,366.03,371.064,375.619,380.564,383.405,386.116,391.116,393.346,398.274,403.274,405.504,408.597,415.628,420.628,422.858,426.251,430.691,435.864,438.547,442.995,450.057,454.622,458.111,462.001,464.231,467.774,473.472,478.995,484.555,486.791,491.418,496.409,501.409,503.639,511.161,520.057,525.517,535.223,538.553" y="560.858" svg_rhmargin="541.053" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ated independently by two reviewers (FPS and AMSW) </text>
  <text x="314.646,319.573,324.573,327.263,330.438,335.438,339.164,347.04,351.546,354.326,357.016,361.527,366.537,371.676,375.5,378.202,383.236,387.801,391.285,395.725,398.707,401.38,406.39,411.39,414.08,418.872,422.202,424.892,427.894,432.909,437.193,439.928,445.083,448.906,451.579,456.589,461.589,464.279,468.843,472.467,475.159,478.059,482.623,486.247,489.027,493.467,496.157,500.784,505.775,510.775,513.465,518.517,523.532,527.972,530.662,533.552,538.552" y="572.858" svg_rhmargin="541.052" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">by formal consideration of inclusion criteria and due to </text>
  <text x="314.646,319.157,324.168,329.113,332.013,336.567,341.512,344.292,346.792,348.632,356.507,360.947,363.856,368.251,373.449,376.451,381.426,386.426,388.926,390.766,393.728,398.719,403.159,405.659,407.499,411.426,415.961,420.599,423.986,428.381,433.381,435.881,437.721,442.697,447.977,451.746,456.844,461.889,465.815,470.365,474.246,476.746,479.246,481.086,488.263,493.548,496.941,501.489,506.034,513.814,518.368,523.313,526.093,528.593,530.433,535.225,538.555" y="584.858" svg_rhmargin="541.055" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">content matching the search purposes. Agreement of </text>
  <text x="314.646,317.647,322.662,326.947,329.682,334.836,338.66,341.333,346.343,351.343,353.843,355.373,360.373,363.703,366.203,367.733,372.149,376.964,381.248,383.984,389.138,392.961,395.634,400.644,405.644,408.144,409.674,414.466,417.796,420.296,421.826,426.801,431.845,436.71,439.619,442.316,446.799,451.239,454.221,456.894,461.904,467.043,470.933,473.433,474.963,479.89,484.89,487.39,488.92,492.012,499.044,504.044,506.544,508.074,511.467,515.907,521.081,523.764,528.212,535.253" y="596.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">inclusion or exclusion of publications by two review-</text>
  <text svg_rhmargin="480.404" x="314.646,319.211,322.7,326.59,329.09,330.1,337.297,341.885,345.775,348.275,349.285,353.7,358.777,363.824,367.217,371.767,375.721,379.648,384.194,389.194,391.694,392.704,397.631,402.631,405.131,406.141,410.624,415.131,417.819,422.315,427.465,430.264,434.704,437.685,440.359,445.369,450.369,452.869,453.879,458.671,462.001,464.501,465.511,468.473,473.464,477.904,480.404" y="608.858" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">ers was expressed by calculation of the </text>
  <text x="481.432" y="608.858" svg_rhmargin="486.232" style="fill:#171615;font-family:CRUCZX+TimesNewRomanPS-ItalicMT;font-size:10.0px;font-style:ITALIC;font-weight:normal;">κ</text>
  <text x="486.12,489.165,494.14,498.647,501.382,506.397,510.756,513.256,515.756,516.766,524.152,527.786,530.686,535.251,538.581" y="608.858" svg_rhmargin="541.081" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">-value. After </text>
  <text x="314.646,318.039,322.575,327.144,331.539,336.738,339.739,344.714,349.714,352.214,352.914,356.592,361.742,364.642,367.422,369.922,370.622,375.133,380.143,385.282,389.209,393.763,398.708,401.488,403.988,404.688,409.767,414.245,417.337,424.399,428.946,433.5,438.5,441.0,441.7,444.662,449.653,454.093,456.593,457.293,460.686,465.126,470.299,472.982,477.431,484.492,489.057,492.546,496.436,498.936,499.636,503.029,507.421,512.46,517.097,520.446,525.624,528.626,533.601,538.601" y="620.858" svg_rhmargin="541.101" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">reaching full consent between the reviewers regarding </text>
  <text x="314.646,317.608,322.599,327.039,329.539,331.159,335.1,339.665,343.058,347.605,352.16,357.367,360.368,365.343,370.343,372.843,374.463,379.255,382.585,385.085,386.705,391.184,396.229,400.15,403.242,406.726,411.296,415.793,418.74,422.704,425.204,427.704,429.324,434.299,439.343,444.208,447.117,449.815,454.297,458.737,461.718,464.391,469.401,474.54,478.43,480.93,482.55,489.612,494.176,497.569,502.009,504.509,506.129,510.055,514.389,517.091,521.653,526.15,529.05,533.596,538.596" y="632.858" svg_rhmargin="541.096" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">the screening of abstracts, publications were selected </text>
  <text x="314.646,317.821,322.821,326.151,328.651,331.652,336.668,340.952,343.687,348.841,352.665,355.338,360.348,365.348,367.848,370.849,375.795,378.685,383.685,386.185,389.863,395.143,398.864,401.826,406.817,411.382,414.712,417.212,421.839,426.935,431.442,434.153,439.172,442.996,445.818,449.7" y="644.858" svg_rhmargin="452.2" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">for inclusion into further analysis.</text>
  <text x="314.646,321.901,326.341,329.362,333.802,336.302,338.122,341.515,346.114,351.212,356.212,359.933,362.914,365.916,370.891,375.891,378.391,380.211,385.221,390.221,392.721,394.541,397.532,405.335,410.2,412.999,417.626,422.571,425.351,427.851,429.671,433.634,438.914,442.64,447.813,450.51,455.485,459.991,462.829,465.329,467.829,469.649,474.694,479.134,482.115,484.798,489.353,494.298,497.245,501.135,503.635,505.455,510.082,515.073,520.073,522.573,524.393,527.384,535.253" y="656.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">Data reporting on implant survival, patients and im-</text>
  <text x="314.646,319.511,322.309,326.937,331.882,334.829,338.719,341.219,342.625,347.578,352.838,360.585,365.664,370.229,373.718,377.608,380.108,381.508,386.136,391.127,396.127,398.627,400.027,405.079,410.359,413.843,418.283,421.264,423.937,428.947,433.947,436.447,437.847,442.639,445.969,448.469,449.869,454.827,459.872,463.799,468.363,472.089,477.065,481.505,484.486,487.16,492.17,497.266,501.772,504.552,507.052,508.452,513.551,518.115,521.739,524.412,529.489,534.662,538.552" y="668.858" svg_rhmargin="541.052" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">plants numbers and duration of observational periods </text>
  <text x="314.646,321.708,326.272,329.665,334.105,336.605,339.435,342.828,347.306,350.398,354.022,356.706,361.146,365.986,370.532,375.532,378.032,380.862,384.51,387.878,392.878,400.658,403.158,405.988,408.99,414.005,418.289,421.024,426.068,431.102,435.647,440.647,443.147,445.977,450.952,455.996,460.861,463.77,466.467,470.95,475.39,478.371,481.045,486.055,491.194,495.075,497.575,500.075,502.905,511.727,516.167,518.825,524.028,529.019,533.565,538.565" y="680.858" svg_rhmargin="541.065" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">were retrieved from included publications. Weighed </text>
  <text x="314.646,322.426,326.962,331.589,336.589,339.089,341.239,346.214,350.72,353.456,358.471,363.02,366.91,369.41,371.56,376.352,379.682,382.182,384.332,388.815,393.757,398.197,400.697,402.847,406.506,411.551,415.991,418.973,421.656,426.21,431.155,433.803,437.149,440.542,444.875,447.674,452.114,455.014,459.56,464.521,467.851,470.351,472.501,477.128,482.119,487.119,489.619,491.769,496.561,499.891,502.391,504.541,507.532,515.335,520.2,522.998,527.626,532.571,535.218" y="692.858" svg_rhmargin="538.548" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">mean values of age (patient-related) and of implant-</text>
  <text x="314.646,318.039,322.373,325.171,329.611,332.512,337.057,342.057,344.512,347.503,355.306,360.171,362.97,367.597,372.542,375.322,377.775,381.739,387.019,390.745,395.918,398.614,403.589,408.096,410.876,413.328,416.813,421.253,424.153,428.593,431.046,433.917,441.412,449.26,454.7,461.032,464.362,466.817,471.444,476.435,481.435,483.89,488.848,493.893,497.819,502.384,506.11,511.085,515.525,518.506,521.179,526.189,531.285,535.792,538.572" y="704.858" svg_rhmargin="541.072" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">related implant survival rate (wmSR) and observational </text>
  <text x="314.646,319.745,324.31,327.934,330.607,335.684,340.857,344.747,347.247,350.128,357.931,365.047,370.255,373.585,376.085,383.147,387.711,391.104,395.544,398.044,402.525,407.032,409.72,414.217,419.367,422.165,426.605,429.506,434.051,439.143,441.643" y="716.858" svg_rhmargin="444.143" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">periods (mOP) were calculated. </text>
  <text x="314.646,319.854,324.86,328.19,330.33,338.11,342.587,345.607,350.082,353.481,358.108,363.204,367.711,370.422,375.441,379.265,382.087,385.977,388.117,391.795,397.065,402.384,407.384,411.718,414.498,416.633,421.26,426.252,431.252,433.392,436.567,441.567,444.96,449.51,453.43,456.21,458.345,463.21,465.904,470.866,473.813,477.703,479.843,483.018,488.018,491.348,493.488,497.995,500.894,503.674,505.809,510.784,515.828,520.693,523.602,526.3,530.782,535.253" y="728.858" svg_rhmargin="538.583" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">For meta-analysis funnel and forest plots for all publica-</text>
  <text x="314.646,317.627,320.301,325.311,330.45,334.34,336.84,338.31,342.937,347.928,352.928,355.428,356.898,360.073,365.073,368.403,370.903,372.373,375.335,380.326,384.766,387.266,388.736,392.7,397.744,402.667,407.952,411.32,416.295,421.333,426.396,430.286,432.786,434.256,439.048,442.378,444.878,446.348,451.323,456.368,461.233,464.142,466.839,471.322,475.762,478.743,481.417,486.427,491.566,495.456,497.956,499.426,506.821,509.512,512.474,517.474,519.974,521.444,526.656,531.096,534.116,538.556" y="740.858" svg_rhmargin="541.056" style="fill:#171615;font-family:EHOOBT+TimesNewRomanPSMT;font-size:10.0px;font-style:NORMAL;font-weight:normal;">tions and for the subgroups of publications with data </text>
 </g>
</svg>
